Researchers have recently confirmed that virtual reality headsets tend to cause a form of motion sickness known as VR sickness, which induces nausea and vomiting. While developmental teams have tried to combat this issue, its prevalence remains common. Many in the industry fear that this will be a major obstacle for virtual reality to be adopted to the general public.
WAT Med attended LifeSciences BC’s Health Networking event on May 17th and had the pleasure to meet Dr. Robert DiRaddo, the Section Head of Simulation and Digital Health at the National Research Council of Canada (NRC). Dr. DiRaddo’s team develops mathematically-based interactive virtual reality and artificial intelligence technology for a wide range of uses, including neurosurgical training for surgeons, flying training for pilots, and anxiety control for airplane passengers.
Dr. DiRaddo expressed his interest in WAT Med’s leading product, EmeTerm™, as a potential solution to nausea-induced vomiting. EmeTerm™’s innovative design and usability has received positive feedback from Dr. DiRaddo and many other medical professionals at the event. The product is in the process of FDA and Canada Health classⅡmedical device application and is estimated to be certified by early 2018.
WAT Med remains in contact with NRC and are looking forward to offer solution for VR sickness and for other collaboration opportunities.